LeMaitre Vascular (LMAT) Lags Q1 Earnings Estimates

Group 1 - LeMaitre Vascular reported quarterly earnings of $0.48 per share, missing the Zacks Consensus Estimate of $0.50 per share, but showing an increase from $0.44 per share a year ago, resulting in an earnings surprise of -4% [1] - The company posted revenues of $59.87 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.59%, compared to year-ago revenues of $53.48 million [2] - Over the last four quarters, LeMaitre has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Group 2 - The stock's immediate price movement will depend on management's commentary during the earnings call, with LeMaitre shares losing about 1.5% since the beginning of the year, while the S&P 500 declined by -5.3% [3] - The current consensus EPS estimate for the coming quarter is $0.59 on revenues of $61.31 million, and for the current fiscal year, it is $2.25 on revenues of $240.41 million [7] - The Zacks Industry Rank indicates that the Medical - Products sector is currently in the bottom 28% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]